Find a Laboratory Karen R. Rabin, MD, PhD

Dr. Karen Rabin’s research focuses on the biology of acute lymphoblastic leukemia (ALL), with a particular interest in children with Down syndrome, including the molecular basis for leukemogenesis in these patients and the basis for their increased risk of treatment-related toxicities. Further study of this specific, genetically homogeneous patient population may generate insights that ultimately have broad applicability in improving our understanding of leukemogenesis and our development of improved treatments in leukemia. Dr. Rabin also has research interests in molecular determinants associated with prognosis in childhood ALL, and identification of the basis for outcome disparities in ALL in Latino children and adolescents.

Dr. Rabin is currently a member of the Children’s Oncology Group (COG) ALL Steering Committee, and has previously held positions of Vice Chair of COG ALL Biology; Vice Chair of the COG Standard Risk and Down syndrome ALL Study AALL1731, and Chair of ALL Classification Study AALL08B1.